"Clinical Research Fellow"

The UCL Centre for Radiopharmaceutical Chemistry (CRC) is a multidisciplinary research centre dedicated to the development and clinical translation of novel biomedical imaging agents. The centre combines cutting-edge chemistry with clinical applications, supporting observational studies and clinical trials to advance precision medicine. The joint UCLH Endocrinology and Endocrine Surgery Departments provide integrated, multidisciplinary care for patients with complex endocrine disorders in thyroid, parathyroid and adrenal pathology. We specialise in adrenal conditions, especially Primary Aldosteronism, and serve as a specialist centre for diagnosing and managing phaeochromocytoma and paraganglioma, providing integrated biochemical testing, advanced imaging, and surgical planning.

The successful candidate will join a dynamic clinical trial team working in collaboration with the UCL CRC and the joint UCLH Endocrinology and Endocrine Surgery Departments, both of which are dedicated to the delivery of IDEAL2. IDEAL2 is a multicentre Phase 2 clinical study evaluating the imaging performance of a novel PET tracer (AldoView) radiopharmaceutical designed to improve diagnostic accuracy in patients with primary aldosteronism.

The main role is a key part of the research team, working in close coordination with the clinical trials unit and Participant Identification Centres (PIC sites). The successful candidate will support multicentre trial activities and contribute meaningfully to a high-impact translational research programme. The position offers a unique opportunity to contribute to cutting-edge endocrine research and help define new clinical pathways in adrenal diagnostics. This post is available on full-time and part-time basis and is eligible for sponsorship.

We are looking for a motivated, detail-oriented clinician with demonstrable expertise in endocrinology—particularly primary aldosteronism and adrenal disorders. The successful candidate will offer strong clinical research experience, ideally in endocrinology or nuclear medicine, with a solid understanding of GCP, regulatory frameworks, and trial protocols.

The successful candidate will support the delivery of a Phase 2 clinical trial, contributing to study visits, safety monitoring, adverse event reporting, and documentation. Excellent communication skills to enable effective collaboration across multidisciplinary teams are required.

The successful candidate will be confident in managing the operational demands of multicentre studies, including recruitment, assessments, data collection, and coordination with sponsors and regulators. GMC registration (or active progression toward it) is required.

As well as the exciting opportunities this role presents, we also offer great benefits, including: 41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days), Additional 5 days’ annual leave purchase scheme, Defined benefit career average revalued earnings pension scheme (CARE), Cycle to work scheme and season ticket loan, Immigration loan, Relocation scheme for certain posts, On-Site nursery, On-site gym, Enhanced maternity/paternity/adoption pay, Employee assistance programme: Staff Support Service, Discounted medical insurance. Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more.

As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people. Our department holds an Athena SWAN Silver award, in recognition of our commitment and demonstrable impact in advancing gender equality.